Table 1.
Study | Year | Location | N | Study design | Primary endpoint | Mortality reported | Type of stent | MACCE definition | Follow up (years) |
---|---|---|---|---|---|---|---|---|---|
EXCEL [7] | 2016 | Multicenter | 1905 | RCT | death, MI, Stroke, | Yes | DES (EES) | death, MI, Stroke, IDR | 3 |
NOBLE [8] | 2016 | Multicenter | 1184 | RCT | death, MI, Stroke, RR | Yes | DES (SES/BES) | death, MI, Stroke, RR | 5 |
LE MANS [18] | 2016 | Multicenter | 105 | RCT | LVEF | Yes | DES/BMS | death, MI, Stroke, TVR | 10 |
PRECOMBAT [17] | 2015 | Multicenter | 600 | RCT | death, MI, Stroke, IDR | Yes | DES (SES) | death, MI, Stroke, IDR | 5 |
SYNTAX [16] | 2014 | Multicenter | 705 | RCT | death, MI, Stroke, RR | Yes | DES (PES) | death, MI, Stroke, RR | 5 |
Abbreviations: MI myocardial infarction, IDR Ischemia driven revascularization, RR repeat revascularization, LVEF left ventricle ejection fraction, TVR target vessel revascularization, RCT randomized clinical trials (see Additional file 5)